Background
Methods
Statistical analysis
Results
characteristic
|
Total sample
|
Clinical interview
|
PHQ-9
|
CES-D (score ≥ = 16)
|
CES-D (score ≥ = 22)
| ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n = 185 (%)
|
MDD
n = 80
|
No MDD
n = 105
|
P
|
MDD
n = 88
|
No MDD
n = 97
|
P
|
MDD
n = 114
|
No MDD
n = 71
|
P
|
MDD
n = 90
|
No MDD
n = 95
|
P
| |
Gender
| |||||||||||||
Male
|
89(48.1)
|
33(41.2)
|
56(53.3)
|
P = 0.10
|
30(34.1)
|
59(60.8)
|
P < 0.001
|
42(36.8)
|
47(66.2)
|
P < 0.001
|
31( 34.4)
|
58(61.1)
|
P < 0.001
|
Female
|
96(51.9)
|
47(58.8)
|
49(46.7)
|
58(65.9)
|
38(39.2)
|
72(63.2)
|
24(33.8)
|
59(65.6)
|
37(38.9)
| ||||
Education
| |||||||||||||
< 8 grades
|
100(54.1)
|
43(53.8)
|
57(54.3)
|
P = 0.94
|
54(61.4)
|
46(47.4)
|
P = 0.05
|
66(57.9)
|
34(47.9)
|
P = 0.18
|
53(58.9)
|
47(49.5)
|
P = 0.19
|
≥ 8grades
|
85(45.9)
|
37(46.2)
|
48(45.7)
|
34(38.6)
|
51(52.6)
|
48(42.1)
|
37(52.1)
|
37(41.1)
|
48(50.5)
| ||||
Insurance
| |||||||||||||
Yes
|
168(92.3)
|
74(93.7)
|
94(91.3)
|
P = 0.54
|
80(90.9)
|
88(93.6)
|
P = 0.49
|
104(92.9)
|
64(91.4)
|
P = 0.72
|
83(92.2)
|
85(92.4)
|
P = 0.96
|
No
|
14(7.7)
|
5(6.3)
|
9(8.7)
|
8(9.1)
|
6(6.4)
|
8(7.1)
|
6(8.6)
|
7(7.8)
|
7(7.6)
| ||||
Medication
| |||||||||||||
Oral
|
121(67.6)
|
50(64.9)
|
71(69.6)
|
P = 0.36
|
54(62.1)
|
67(72.8)
|
P = 0.30
|
74(66.1)
|
47(70.1)
|
P = 0.83
|
54(60.7)
|
67(74.4)
|
P = 0.14
|
Insulin
|
25(14)
|
14(18.2)
|
11(10.8)
|
14(16.1)
|
11(12.0)
|
16(14.3)
|
9(13.4)
|
15(16.9)
|
10(11.1)
| ||||
Oral & Insulin
|
34(18.4)
|
13(16.9)
|
20(19.6)
|
19(21.8)
|
14(15.2)
|
22(19.6)
|
11(16.4)
|
20(22.5)
|
13(14.4)
| ||||
Family income
| |||||||||||||
low
|
95(51.4)
|
43(53.8)
|
52(49.5)
|
P = 0.56
|
49(55.7)
|
46(47.4)
|
P = 0.26
|
63(55.3)
|
32(45.1)
|
P = 0.17
|
49(54.4)
|
46(48.4)
|
P = 0.41
|
middle-high
|
90(48.6)
|
37(46.2)
|
53(50.5)
|
39(44.3)
|
51(52.6)
|
51(44.7)
|
39(54.9)
|
41(45.6)
|
49(51.6)
| ||||
Age (mean ± SD)
|
56.17 ± 9.60
|
54.38 ± 9.16
|
57.53 ± 9.74
|
P = 0.02
|
54.88 ± 10.13
|
57.34 ± 8.98
|
P = 0.08
|
55.87 ± 10.31
|
56.65 ± 8.37
|
P = 0.59
|
55.14 ± 10.32
|
57.14 ± 8.81
|
P = 0.15
|
HbA1C
|
8.10 ± 1.92
|
8.14 ± 1.98
|
8.06 ± 1.89
|
P = 0.80
|
8.32 ± 2.01
|
7.91 ± 1.84
|
P = 0.18
|
8.25 ± 1.99
|
7.86 ±1.79
|
P = 0.21
|
8.26 ± 2.01
|
7.95 ± 1.84
|
P = 0.32
|
BMI
|
28.33 ± 4.72
|
28.52 ± 4.33
|
28.20 ± 5.00
|
P = 0.68
|
28.55 ± 4.56
|
28.16 ± 4.87
|
P = 0.60
|
28.60 ± 4.68
|
27.92 ± 4.80
|
P = 0.38
|
28.58 ± 4.35
|
28.12 ± 5.03
|
P = 0.55
|
Diabetes duration (year ± SD )
|
9.83 ± 7.38
|
11.02 ± 7.26
|
8.93 ± 7.37
|
P = 0.05
|
9.22 ± 6.93
|
10.38 ± 7.75
|
P = 0.29
|
9.91 ± 7.06
|
9.70 ± 7.91
|
P = 0.85
|
9.77 ± 6.87
|
9.88 ± 7.86
|
P = 0.91
|
Sensitivity % | Specificity % | + LR | - LR | |
---|---|---|---|---|
PHQ-9 algorithm | 77.5 (66.5-85.7) | 75.2(65.6-82.9) | 3.1(2.1-4.4) | 0.2(0.1-0.4) |
PHQ-9(score ≥ 10) | 83.8(73.4-90.7) | 65.7(55.7-74.5) | 2.4(1.8-3.2) | 0.2(0.1-0.4) |
PHQ-9(score ≥ 13) | 73.8(62.5-82.6) | 76.2(66.6-83.7) | 3.1(2.1-4.4) | 0.3(0.2-0.5) |
CES-D(score ≥ 16) | 90 (80.7-95.2) | 60 (49.9-69.2) | 2.2(1.7-2.8) | 0.2(0.0-0.3) |
CES-D(score ≥ 22) | 82.5(72.-89.7) | 77.1(67.7-84.5) | 3.6(2.5-5.2) | 0.2(0.1-0.3) |
CES-D(score ≥ 23) | 78.8(67.8-86.7) | 77.1(67.7-84.5) | 3.4(2.3-4.9) | 0.2(0.1-0.4) |